Optinose, Inc. offers health care services. The Hospital offers ear, nose, and throat surgery, as well as provides treating of nasal and sinus diseases, research, development, medication of migraine, clinical data analysis, diagnosis, and other services. Optinose operates worldwide.

Current Report (Form 8-K | Period ending 2024-12-23)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Optinose Inc (OPTN US)

Current Report (Form 8-K | Period ending 2024-12-23)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-10-16)

Current Report (Form 8-K | Period ending 2024-09-24)

Quarterly Report (Form 10-Q | Period ending 2024-06-30)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)